Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ellis

Showing results (811-820 of 1,150) with videos related to

Pageof 115
Sort By:
The American Journal of Cardiology|January 17, 2012
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary interventionDharam J Kumbhani, Mehdi H Shishehbor, Joshua M Willis, et al.
The American Journal of Cardiology|September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomesJuhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The American Journal of Cardiology|July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionDeepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.
JACC. Cardiovascular Interventions|May 21, 2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial ProgramGregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
Journal of the American College of Cardiology|March 15, 1993
Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control studyA M Lincoff, E J Topol, A T Chapekis, et al.
The American Journal of Cardiology|April 10, 2012
Pilot candidate gene analysis of patients ≥ 60 years old with aortic stenosis involving a tricuspid aortic valveStephen G Ellis, Sandra Dushman-Ellis, May M Luke, et al.
Circulation|August 29, 2001
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary interventionD P Chew, D L Bhatt, M A Robbins, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
Nature Biotechnology|April 19, 2011
Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cellsMatthew J Frontini, Zengxuan Nong, Robert Gros, et al.
Circulation|November 1, 1994
Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarctionS G Ellis, E R da Silva, G Heyndrickx, et al.
Pageof 115

Showing results (811-820 of 1,150) with videos related to

Sort By:
Pageof 115
The American Journal of Cardiology|January 17, 2012
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary interventionDharam J Kumbhani, Mehdi H Shishehbor, Joshua M Willis, et al.
The American Journal of Cardiology|September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomesJuhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The American Journal of Cardiology|July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionDeepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.
JACC. Cardiovascular Interventions|May 21, 2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial ProgramGregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
Journal of the American College of Cardiology|March 15, 1993
Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control studyA M Lincoff, E J Topol, A T Chapekis, et al.
The American Journal of Cardiology|April 10, 2012
Pilot candidate gene analysis of patients ≥ 60 years old with aortic stenosis involving a tricuspid aortic valveStephen G Ellis, Sandra Dushman-Ellis, May M Luke, et al.
Circulation|August 29, 2001
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary interventionD P Chew, D L Bhatt, M A Robbins, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
Nature Biotechnology|April 19, 2011
Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cellsMatthew J Frontini, Zengxuan Nong, Robert Gros, et al.
Circulation|November 1, 1994
Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarctionS G Ellis, E R da Silva, G Heyndrickx, et al.
Pageof 115